Talas, Elsa .
HRN: 18-77-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2025
CEFUROXIME 500MG (TAB)
06/06/2025
06/13/2025
PO
500 Mg
BID
UTI
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: